Literature DB >> 8482834

Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity.

G Girolomoni1, S Pastore, V Zacchi, A Cavani, A Marconi, A Giannetti.   

Abstract

Phosphatidylserine (PS) modulates several immune functions in vitro, including T cell activation, antibody and cytokine production, and macrophage growth. In the present work we studied the effects of PS on the induction of contact hypersensitivity (CH) in mice. BALB/c mice painted with PS (9.4-75 mg/kg) and with a sensitizing dose of DNFB or oxazolone on the same skin site exhibited a dose-dependent augmentation of CH reactions to either DNFB (> 60%) or oxazolone (> 35%), respectively. Bovine brain PS-enriched phospholipid mixture, lyso-PS, and dipalmitoyl-PS also induced similar enhanced CH responses, whereas phosphatidylglycerols had no effect. Increased CH was observed only when PS was applied from 2 days before to 12 h after DNFB. Immunization of naive syngeneic mice with skin grafts that were treated with PS and DNFB also led to enhanced (> 50%) CH responses. In addition, immunization by iv injection of epidermal cell suspensions enriched for Langerhans cells (LC) or of purified LC that were treated with PS (1-100 microM, 30 min, 37 degrees C), and then modified in vitro with DNBS (1 mg/ml, 30 min, 37 degrees C) led to increased (> 30-75%) CH responses in recipient syngeneic animals. Finally, adoptive transfer of DNFB-immune lymph node cells obtained from mice that were treated with PS induced augmented CH responses in recipient animals. The results suggest that PS is capable of up-regulating the induction of CH in mice by stimulating the APC function of epidermal LC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482834

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer.

Authors:  Michael R Shurin; Alla I Potapovich; Yulia Y Tyurina; Irina L Tourkova; Galina V Shurin; Valerian E Kagan
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

2.  Lysophospholipids activate ovarian and breast cancer cells.

Authors:  Y Xu; X J Fang; G Casey; G B Mills
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

3.  Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine.

Authors:  C Calderón; Z H Huang; D A Gage; E M Sotomayor; D M Lopez
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

4.  Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo.

Authors:  P Paglia; G Girolomoni; F Robbiati; F Granucci; P Ricciardi-Castagnoli
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.